Expenses for patients with and without expenditures | ||||
---|---|---|---|---|
 | Number of episodes | Mean* | Median# | Range |
Episodes with complete cost information (with and without expenses) | 50 | 24.15 | 10 | 0.00 – 226.04 |
ADR Classification: | ||||
  Probable | 31 | 28.85 | 14.61~ | 0.00 –226.04 |
  Possible | 19 | 16.48 | 3.48~ | 0.00 – 115.91 |
Treatment costs by admission status: | ||||
  Admitted | 22 | 47.18** | 30.83** | 0.00 – 226.04 |
  Not admitted | 28 | 6.05** | 2.61** | 0.00 – 35.39 |
Treatment costs by survivorship | ||||
Costs for patients surviving | 43 | 17.15 | 7.80^ | 0.00 – 125.87 |
Costs for Patients dying | 7 | 63.89 | 28.74^ | 0.00 – 226.04 |
Number of visits: | ||||
  One | 30 | 7.24** | 2.23^ | 0.00 – 44.04 |
  Two | 15 | 32.01** | 28.74^ | 1.74 – 115.91 |
  Three | 3 | 72.09 | 46.48 | 43.91 – 125.87 |
  Four | 2 | 146.93** | 146.93^ | 67.83 – 226.04 |
Study district: | ||||
  Rufiji | 28 | 21.68 | 3.61^ | 0.00 – 226.04 |
  Kilombero / Ulanga | 22 | 27.29 | 21.80^ | 0.00 – 115.91 |
Age group: | ||||
  Under 5 years | 13 | 11.60 | 5.99 | 0 – 32.91 |
  5 years or over | 37 | 28.11 | 10.78 | 0 – 226.04 |
By drug use | ||||
  AS only | 1 | 9.74 | 9.74^ | 9.74 – 9.74 |
  SP only | 35 | 29.02 | 19.61^ | 0 – 226.04 |
  SP + Artesunate | 14 | 13.00 | 3.61^ | 0 – 125.87 |